Rossmore Private Capital boosted its holdings in CME Group Inc (NASDAQ:CME) by 97.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,055 shares of the financial services provider’s stock after acquiring an additional 2,000 shares during the period. Rossmore Private Capital’s holdings in CME Group were worth $690,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Buckley Wealth Management LLC bought a new stake in CME Group in the 3rd quarter valued at $201,000. First Trust Advisors LP raised its stake in CME Group by 11.0% in the 3rd quarter. First Trust Advisors LP now owns 308,620 shares of the financial services provider’s stock valued at $52,530,000 after acquiring an additional 30,572 shares during the period. Steward Partners Investment Advisory LLC raised its stake in CME Group by 42.8% in the 3rd quarter. Steward Partners Investment Advisory LLC now owns 16,471 shares of the financial services provider’s stock valued at $2,804,000 after acquiring an additional 4,939 shares during the period. Calamos Advisors LLC bought a new stake in CME Group in the 3rd quarter valued at $5,276,000. Finally, IFM Investors Pty Ltd raised its stake in CME Group by 16.9% in the 3rd quarter. IFM Investors Pty Ltd now owns 17,867 shares of the financial services provider’s stock valued at $3,041,000 after acquiring an additional 2,579 shares during the period. Institutional investors and hedge funds own 84.30% of the company’s stock.
CME stock traded up $3.26 during trading hours on Friday, hitting $180.73. 57,040 shares of the stock were exchanged, compared to its average volume of 1,574,709. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.08 and a quick ratio of 1.08. The stock has a market capitalization of $61.53 billion, a price-to-earnings ratio of 37.73, a PEG ratio of 3.45 and a beta of 0.64. CME Group Inc has a 12 month low of $132.77 and a 12 month high of $183.79.
In related news, President Bryan T. Durkin sold 11,509 shares of the firm’s stock in a transaction on Monday, August 6th. The stock was sold at an average price of $162.01, for a total value of $1,864,573.09. Following the transaction, the president now owns 64,862 shares in the company, valued at $10,508,292.62. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction on Thursday, October 11th. The stock was sold at an average price of $179.86, for a total value of $449,650.00. Following the completion of the transaction, the chief financial officer now owns 32,720 shares in the company, valued at approximately $5,885,019.20. The disclosure for this sale can be found here. Insiders sold 29,188 shares of company stock worth $4,973,607 in the last 90 days. 0.43% of the stock is owned by company insiders.
Several research analysts have weighed in on CME shares. BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 28th. Wells Fargo & Co increased their price objective on CME Group from $170.00 to $175.00 and gave the stock a “market perform” rating in a research report on Monday, July 9th. Compass Point started coverage on CME Group in a research report on Monday, July 9th. They set a “neutral” rating and a $170.00 price objective on the stock. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating in a research report on Wednesday, August 22nd. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $190.00 price objective on shares of CME Group in a research report on Wednesday, September 5th. Five equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. CME Group presently has a consensus rating of “Buy” and a consensus target price of $181.38.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Featured Article: What are the economic characteristics of a bear market?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.